Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06327061 · ClinicalTrials.gov registry record · NA

Social Network Overdose Prevention and Education Intervention

A NA study of Drug Overdose, sponsored by Johns Hopkins Bloomberg School of Public Health.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT06327061: Recruiting NA study of Drug Overdose, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT06327061 is a NA study of Drug Overdose that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 600 participants, above the 362-participant average among 5 other Drug Overdose trials with a reported enrollment target (66% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06327061, a NA study of Drug Overdose, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs).

Primary Outcome

Number of drug overdoses in prior three months

Conditions Studied

Interventions

  • BEHAVIORAL Network overdose prevention
  • BEHAVIORAL Standard of care health education

Study Locations (1)

Maryland

  • Johns Hopkins Bloomberg School of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2024-06-01
Est. Completion 2029-04-01
Phase NA

What NCT06327061 shows while recruiting

NCT06327061 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 362-participant average among 5 other Drug Overdose trials with a reported enrollment target (66% higher).

The record links to 1 condition, with Drug Overdose appearing as the primary indexed condition, and to 2 interventions - of which Network overdose prevention is the first listed.

NCT06327061 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06327061 about?

NCT06327061 is a clinical study titled "Social Network Overdose Prevention and Education Intervention". The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs).

What is the current status of trial NCT06327061?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-06-01. Estimated completion is 2029-04-01.

What conditions does trial NCT06327061 study?

This clinical trial studies the following conditions: Drug Overdose.

What interventions are being tested in trial NCT06327061?

The interventions under investigation include: Network overdose prevention (BEHAVIORAL), Standard of care health education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06327061?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06327061 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Overdose

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06327061, the US trial registry maintained by the National Library of Medicine. NCT06327061 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.